Tengjun Biotechnology CEO/CFO and director Ruiming Zhou resigns; Qingbao Wang appointed successor

Tengjun Biotechnology Corp.

Ruiming Zhou resigned as director, CEO and CFO of Tengjun Biotechnology, effective November 16, 2023; no disagreement with company.
Board appointed Qingbao Wang as director, CEO and CFO effective November 16, 2023, until next annual meeting.
Wang previously served as director of Shandong Hawei Food Co., Ltd since June 2000; holds technical secondary school degree.
No arrangements or understandings between Wang and any other persons regarding his appointment; no related party transactions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ruiming Zhou

Chief Executive Officer

Tengjun Biotechnology Corp.

Effective: 2023-11-16
Successor: Qingbao Wang
Filed: November 17, 2023, 6:59 PM ET

Effective as of November 16, 2023, Ruiming Zhou resigned from his position as a member of the Board of Directors (the “Board”), the CEO and CFO of Tengjun Biotechnology Corp (the “Company”).

Appointed

Qingbao Wang

Chief Executive Officer

Tengjun Biotechnology Corp.

Effective: 2023-11-16
Filed: November 17, 2023, 6:59 PM ET

Effective as of November 16, 2023, the Board appointed Qingbao Wang as a member of the Board, the CEO and CFO of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ruiming Zhou resigned as Chief Executive Officer at Tengjun Biotechnology Corp..

Action: resigned
Role: Chief Executive Officer

Exact text from the filing

Effective as of November 16, 2023, Ruiming Zhou resigned from his position as a member of the Board of Directors (the “Board”), the CEO and CFO of Tengjun Biotechnology Corp (the “Company”).

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Qingbao Wang was appointed as Chief Executive Officer at Tengjun Biotechnology Corp..

Action: appointed
Role: Chief Executive Officer

Exact text from the filing

Effective as of November 16, 2023, the Board appointed Qingbao Wang as a member of the Board, the CEO and CFO of the Company

View on SEC.gov

Source: SEC EDGAR

accession 0001213900-23-088327

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.